Spots Global Cancer Trial Database for Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
Official Title: Non-Comparative, Multi-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab (BMS-936558) in Classical Hodgkin Lymphoma (cHL) Subjects
Study ID: NCT02181738
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Nivolumab in previously treated (cohorts, A, B \& C) or newly diagnosed (cohort D) classical Hodgkin Lymphoma participants.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0030, Los Angeles, California, United States
Local Institution - 0009, Los Angeles, California, United States
Local Institution - 0001, Atlanta, Georgia, United States
Local Institution - 0002, Boston, Massachusetts, United States
Local Institution - 0025, Boston, Massachusetts, United States
Local Institution - 0041, Boston, Massachusetts, United States
Local Institution - 0008, Detroit, Michigan, United States
Local Institution - 0003, Rochester, Minnesota, United States
Local Institution - 0047, Hackensack, New Jersey, United States
Local Institution - 0040, Basking Ridge, New York, United States
Local Institution - 0005, New York, New York, United States
Local Institution - 0006, Allentown, Pennsylvania, United States
Local Institution - 0004, Nashville, Tennessee, United States
Local Institution - 0007, Houston, Texas, United States
Local Institution - 0032, Innsbruck, , Austria
Local Institution - 0031, Wien, , Austria
Local Institution - 0014, B-leuven, , Belgium
Local Institution - 0015, Gent, , Belgium
Local Institution - 0046, Vancouver, British Columbia, Canada
Local Institution - 0042, Toronto, Ontario, Canada
Local Institution - 0044, Praha 2, , Czechia
Local Institution - 0037, Berlin, , Germany
Local Institution - 0036, Hamburg, , Germany
Local Institution - 0033, Koeln, , Germany
Local Institution - 0034, Ulm, , Germany
Local Institution - 0019, Bologna, , Italy
Local Institution - 0020, Napoli, , Italy
Local Institution - 0035, Rozzano (milano), , Italy
Local Institution - 0016, Amsterdam, , Netherlands
Local Institution - 0038, Groningen, , Netherlands
Local Institution - 0017, Utrecht, , Netherlands
Local Institution - 0022, Hospitalet Llobregat- Barcelona, , Spain
Local Institution - 0027, Majadahonda - Madrid, , Spain
Local Institution - 0023, Marbella, , Spain
Local Institution - 0043, Swansea, Carmarthenshire, United Kingdom
Local Institution - 0012, Withington, Manchester, United Kingdom
Local Institution - 0026, Oxford, Oxfordshire, United Kingdom
Local Institution - 0013, Sutton, , United Kingdom
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
